BETHLEHEM, Pa., Feb. 09, 2026 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ: OSUR) has scheduled its regular earnings conference call covering fourth quarter 2025 financial results and ...
BETHLEHEM, Pa.- OraSure Technologies, the Bethlehem-based medical device maker, is cutting jobs. A company spokesperson told ...
“Expanding access to HIV testing options is a critical component in the global effort to end the HIV epidemic,” said Carrie Eglinton Manner, President and CEO of OraSure, in a news release. “Early ...
OraSure Technologies said Friday that it is reducing a “mid-single digits percent” of its workforce, including 10 at its ...
Growth stocks can be some of the most exciting picks in the market, as these high-flyers can captivate investors’ attention, and produce big gains as well. However, these can also lead on the downside ...
The Canadian Press on MSN
Oral HIV self-test approved for sale, advocates say it's key to elimination
TORONTO — ...
OraSure Technologies, Inc. (“OraSure”) (NASDAQ: OSUR), a leader in point-of-need and home diagnostic tests and sample management solutions, today announced its OraQuick™ HIV Self-Test has received a ...
OraSure Technologies, Inc. has announced that it will hold anearnings conference callon May 7, 2025, at 5 p.m. ET to discuss its first quarter financial results and business developments. The call ...
Bethlehem’s OraSure Technologies is examining whether technology it developed for its in-home HIV test could be used to screen for Ebola. The company has been approached by federal agencies and ...
After a steep drop in COVID-19 cases in the U.S. earlier this year sent test makers scaling back production of their rapid antigen and PCR offerings, they’re now scrambling to catch up with the sudden ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results